CVS Health Company Insiders
| CVS Stock | USD 59.85 0.11 0.18% |
Slightly above 84 percent of CVS Health's insiders are selling. The analysis of insiders' sentiment of trading CVS Health Corp stock suggests that a fairly large number of insiders are terrified at this time. CVS Health employs about 219 K people. The company is managed by 46 executives with a total tenure of roughly 219 years, averaging almost 4.0 years of service per executive, having 4760.87 employees per reported executive.
| Larry Merlo CEO President, Chief Executive Officer, Director |
| David Dorman Chairman Independent Chairman of the Board |
CVS Health's Insider Buying Vs Selling
16
Selling | Buying |
Latest Trades
| 2024-10-24 | Thomas R. Suozzi | Disposed @ 56.11 | |||
| 2024-08-26 | Tommy Tuberville | Disposed @ 58.7 | |||
| 2024-06-27 | Earl Blumenauer | Disposed @ 58.37 | |||
| 2024-05-17 | William R. Keating | Disposed @ 57.68 | |||
| 2024-05-02 | Edward J Ludwig | Acquired 1000 @ 53.88 | View | ||
| 2024-02-16 | Prem S Shah | Disposed 29473 @ 76.95 | View |
Monitoring CVS Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of CVS Health's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of CVS Health Corp. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe CVS Health's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
CVS |
CVS Health's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with CVS Health's future performance. Based on our forecasts, it is anticipated that CVS will maintain a workforce of slightly above 219000 employees by December 2024.CVS Health's latest congressional trading
Congressional trading in companies like CVS Health Corp, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in CVS Health by those in governmental positions are based on the same information available to the general public.
| 2024-11-13 | Representative Thomas Suozzi | Acquired Under $15K | Verify | ||
| 2024-10-08 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-09-12 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2024-07-22 | Representative Michael McCaul | Acquired Under $15K | Verify | ||
| 2024-07-08 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-07-06 | Representative Earl Blumenauer | Acquired Under $15K | Verify | ||
| 2024-05-22 | Representative William R Keating | Acquired Under $15K | Verify | ||
| 2024-01-17 | Senator Jerry Moran | Acquired Under $15K | Verify | ||
| 2024-01-16 | Senator Jerry Moran | Acquired Under $15K | Verify | ||
| 2023-10-20 | Senator Pete Ricketts | Acquired $50K to $100K | Verify | ||
| 2023-07-05 | Representative Dwight Evans | Acquired Under $15K | Verify | ||
| 2023-06-15 | Representative William R Keating | Acquired Under $15K | Verify | ||
| 2021-10-12 | Representative Earl Blumenauer | Acquired $15K to $50K | Verify | ||
| 2021-10-05 | Representative Earl Blumenauer | Acquired $15K to $50K | Verify | ||
| 2021-01-19 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2020-06-03 | Representative Earl Blumenauer | Acquired Under $15K | Verify | ||
| 2020-01-23 | Representative John Rutherford | Acquired Under $15K | Verify | ||
| 2020-01-20 | Representative Mo Brooks | Acquired Under $15K | Verify | ||
| 2019-12-12 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2019-08-15 | Senator John Hoeven | Acquired $50K to $100K | Verify | ||
| 2019-07-29 | Senator Thom Tillis | Acquired Under $15K | Verify | ||
| 2019-06-14 | Senator Thom Tillis | Acquired Under $15K | Verify | ||
| 2019-06-13 | Representative Bill Flores | Acquired Under $15K | Verify | ||
| 2019-06-11 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2019-06-10 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2019-05-08 | Representative Brian Mast | Acquired $50K to $100K | Verify | ||
| 2019-03-01 | Senator John Reed | Acquired Under $15K | Verify | ||
| 2019-02-27 | Senator Thom Tillis | Acquired Under $15K | Verify | ||
| 2019-01-11 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2019-01-08 | Representative Steve Cohen | Acquired $15K to $50K | Verify | ||
| 2018-12-12 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2018-06-14 | Senator John Hoeven | Acquired $50K to $100K | Verify | ||
| 2018-05-10 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2018-05-09 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2017-06-06 | Senator Susan M Collins | Acquired $15K to $50K | Verify | ||
| 2017-06-05 | Senator Susan M Collins | Acquired $15K to $50K | Verify | ||
| 2016-12-16 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2016-12-15 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2016-11-08 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2016-11-07 | Senator Gary Peters | Acquired Under $15K | Verify |
CVS Health Management Team Effectiveness
The company has Return on Asset of 0.0237 % which means that on every $100 spent on assets, it made $0.0237 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.067 %, implying that it generated $0.067 on every 100 dollars invested. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CVS Health's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.06 in 2024, whereas Return On Capital Employed is likely to drop 0.08 in 2024. At this time, CVS Health's Intangibles To Total Assets are comparatively stable compared to the past year. Debt To Assets is likely to gain to 0.33 in 2024, whereas Other Assets are likely to drop slightly above 4.8 B in 2024.Common Stock Shares Outstanding is likely to drop to about 984.2 M in 2024. Net Income Applicable To Common Shares is likely to drop to about 3.7 B in 2024
CVS Health Workforce Comparison
CVS Health Corp is rated second in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 971,061. CVS Health totals roughly 219,000 in number of employees claiming about 23% of equities under Health Care industry.
CVS Health Profit Margins
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.02 %, which entails that for every 100 dollars of revenue, it generated $0.02 of operating income.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.29 | 0.1521 |
|
| |||||
| Operating Profit Margin | 0.0631 | 0.0384 |
|
| |||||
| Pretax Profit Margin | 0.053 | 0.0312 |
|
|
CVS Health Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CVS Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on CVS Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CVS Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-06-01 | 3.1 | 31 | 10 | 765,332 | 117,898 |
| 2024-03-01 | 0.7143 | 5 | 7 | 171,148 | 50,608 |
| 2023-12-01 | 3.2 | 16 | 5 | 112,898 | 3,572 |
| 2023-06-01 | 2.875 | 23 | 8 | 996,712 | 236,161 |
| 2023-03-01 | 0.5714 | 4 | 7 | 470,985 | 17,193 |
| 2022-12-01 | 2.3333 | 14 | 6 | 155,266 | 467,407 |
| 2022-09-01 | 0.8 | 4 | 5 | 133,364 | 112,031 |
| 2022-06-01 | 1.44 | 36 | 25 | 700,275 | 650,540 |
| 2022-03-01 | 0.5313 | 17 | 32 | 1,871,178 | 482,777 |
| 2021-12-01 | 1.3846 | 18 | 13 | 347,504 | 670,012 |
| 2021-09-01 | 0.5 | 1 | 2 | 3,000 | 29,205 |
| 2021-06-01 | 0.8857 | 31 | 35 | 1,600,670 | 1,161,697 |
| 2021-03-01 | 0.697 | 23 | 33 | 1,651,822 | 1,487,387 |
| 2020-12-01 | 2.5 | 15 | 6 | 79,237 | 69,715 |
| 2020-06-01 | 2.0 | 42 | 21 | 3,987,010 | 141,679 |
| 2020-03-01 | 0.5185 | 14 | 27 | 712,485 | 897,854 |
| 2019-12-01 | 3.0 | 18 | 6 | 52,876 | 152,907 |
| 2019-09-01 | 0.5 | 2 | 4 | 26,555 | 52,388 |
| 2019-06-01 | 1.8333 | 33 | 18 | 2,521,147 | 321,502 |
| 2019-03-01 | 1.1364 | 25 | 22 | 668,086 | 1,092,834 |
| 2018-12-01 | 1.0526 | 40 | 38 | 1,946,312 | 765,120 |
| 2018-09-01 | 0.5 | 2 | 4 | 17,737 | 39,612 |
| 2018-06-01 | 0.6774 | 21 | 31 | 1,173,229 | 252,619 |
| 2018-03-01 | 0.3478 | 8 | 23 | 58,231 | 387,007 |
| 2017-12-01 | 4.0 | 12 | 3 | 42,313 | 70,539 |
| 2017-09-01 | 0.4 | 6 | 15 | 564,683 | 1,233,831 |
| 2017-06-01 | 1.3438 | 43 | 32 | 1,711,884 | 691,548 |
| 2017-03-01 | 0.7407 | 20 | 27 | 458,935 | 599,867 |
| 2016-06-01 | 1.6 | 40 | 25 | 1,103,446 | 295,380 |
| 2016-03-01 | 1.2 | 18 | 15 | 312,789 | 296,769 |
| 2015-12-01 | 3.0 | 12 | 4 | 37,554 | 47,981 |
| 2015-09-01 | 0.6154 | 8 | 13 | 123,229 | 111,799 |
| 2015-06-01 | 1.4074 | 38 | 27 | 875,336 | 248,042 |
| 2015-03-01 | 1.2222 | 22 | 18 | 843,065 | 1,356,034 |
| 2014-12-01 | 1.6667 | 15 | 9 | 225,266 | 126,929 |
| 2014-09-01 | 0.4615 | 6 | 13 | 229,632 | 415,448 |
| 2014-06-01 | 2.1053 | 40 | 19 | 1,082,236 | 170,764 |
| 2014-03-01 | 0.7143 | 10 | 14 | 478,950 | 722,350 |
| 2013-12-01 | 3.3333 | 10 | 3 | 50,739 | 86,028 |
| 2013-09-01 | 0.5 | 1 | 2 | 562.00 | 1,690 |
| 2013-06-01 | 2.0909 | 23 | 11 | 876,744 | 257,397 |
| 2013-03-01 | 0.8889 | 8 | 9 | 90,543 | 42,402 |
| 2012-12-01 | 4.0 | 8 | 2 | 20,616 | 98,555 |
| 2012-09-01 | 0.9167 | 11 | 12 | 516,632 | 543,314 |
| 2012-06-01 | 2.3333 | 21 | 9 | 896,254 | 204,894 |
| 2012-03-01 | 0.9167 | 11 | 12 | 254,707 | 327,204 |
| 2011-12-01 | 2.0 | 14 | 7 | 154,485 | 202,626 |
| 2011-09-01 | 0.4 | 2 | 5 | 53,334 | 113,775 |
| 2011-06-01 | 2.8889 | 26 | 9 | 987,728 | 457,481 |
| 2011-03-01 | 0.6667 | 10 | 15 | 120,564 | 214,926 |
| 2010-12-01 | 1.3333 | 12 | 9 | 275,366 | 448,122 |
| 2010-06-01 | 5.0 | 25 | 5 | 685,087 | 22,230 |
| 2010-03-01 | 0.2963 | 8 | 27 | 227,549 | 381,138 |
| 2009-12-01 | 1.8571 | 13 | 7 | 275,368 | 446,846 |
| 2009-09-01 | 0.375 | 3 | 8 | 300,000 | 621,337 |
| 2009-06-01 | 1.8235 | 31 | 17 | 1,324,976 | 946,902 |
| 2009-03-01 | 0.8 | 4 | 5 | 42,711 | 7,255 |
| 2008-12-01 | 15.0 | 15 | 1 | 279,730 | 0.00 |
| 2008-06-01 | 4.1429 | 29 | 7 | 1,040,190 | 348,095 |
| 2008-03-01 | 1.3478 | 31 | 23 | 537,680 | 1,018,325 |
| 2007-12-01 | 3.2857 | 23 | 7 | 123,881 | 234,288 |
| 2007-09-01 | 1.05 | 21 | 20 | 1,762,952 | 3,568,388 |
| 2007-06-01 | 1.5172 | 44 | 29 | 1,811,751 | 2,303,110 |
| 2007-03-01 | 25.6667 | 77 | 3 | 14,209,304 | 323,838 |
| 2006-12-01 | 10.0 | 20 | 2 | 209,730 | 332,406 |
| 2006-09-01 | 4.5 | 9 | 2 | 444.00 | 0.00 |
| 2006-03-01 | 17.0 | 17 | 1 | 26,361 | 48,000 |
| 2005-09-01 | 1.5714 | 11 | 7 | 183,352 | 336,096 |
| 2005-06-01 | 2.25 | 9 | 4 | 41,405 | 68,382 |
| 2005-03-01 | 3.2857 | 23 | 7 | 285,904 | 321,604 |
| 2004-12-01 | 5.0 | 5 | 1 | 1,851 | 650.00 |
| 2004-09-01 | 5.0 | 5 | 1 | 194.00 | 0.00 |
| 2004-06-01 | 1.1667 | 7 | 6 | 107,469 | 148,986 |
| 2004-03-01 | 1.4286 | 10 | 7 | 199,393 | 34,000 |
| 2003-12-01 | 0.7 | 7 | 10 | 96,158 | 182,162 |
CVS Health Notable Stakeholders
A CVS Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CVS Health often face trade-offs trying to please all of them. CVS Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CVS Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Vijay Patel | Senior CoFounder | Profile | |
| Karen Lynch | President, Chief Executive Officer, Director | Profile | |
| Larry Merlo | President, Chief Executive Officer, Director | Profile | |
| David Dorman | Independent Chairman of the Board | Profile | |
| Shawn Guertin | Chief Financial Officer, Executive Vice President | Profile | |
| Joshua Flum | Executive Vice President, Chief Strategy and Business Development Officer | Profile | |
| Troyen Brennan | Executive Vice President Chief Medical Officer | Profile | |
| Prem Shah | Executive Vice President, Chief Pharmacy Officer and Co-President of Retail | Profile | |
| Lisa Bisaccia | Chief Human Resource Officer, Executive Vice President | Profile | |
| Thomas Moriarty | Executive Vice President, General Counsel, Chief Policy and External Affairs Officer | Profile | |
| James Clark | Senior Vice President - Controller, Chief Accounting Officer | Profile | |
| Eva Boratto | Chief Financial Officer, Executive Vice President | Profile | |
| Prem PharmD | Group President | Profile | |
| Jonathan Roberts | Chief Operating Officer, Executive Vice President | Profile | |
| MPP MD | Senior President | Profile | |
| Michelle Peluso | Executive Vice President, Chief Customer Officer and Co-President of Retail | Profile | |
| Thomas Cowhey | Executive CFO | Profile | |
| Edward Ludwig | Independent Director | Profile | |
| Mary Schapiro | Independent Director | Profile | |
| Fernando Aguirre | Independent Director | Profile | |
| NancyAnn DeParle | Independent Director | Profile | |
| JeanPierre Millon | Independent Director | Profile | |
| Alecia DeCoudreaux | Independent Director | Profile | |
| William Weldon | Independent Director | Profile | |
| Tony White | Independent Director | Profile | |
| Anne Finucane | Independent Director | Profile | |
| Roger Farah | Independent Director | Profile | |
| FACEP MD | VP Officer | Profile | |
| Samrat Esq | Chief VP | Profile | |
| Katerina Guerraz | Chief VP | Profile | |
| Sreekanth MD | Executive Officer | Profile | |
| Laurence McGrath | Senior Relations | Profile | |
| Laurie Havanec | Chief People Officer, Executive Vice President | Profile | |
| Norman Greve | Chief Officer | Profile | |
| C Brown | Independent Director | Profile | |
| David CEBS | Executive Caremark | Profile | |
| Tilak Mandadi | Data, Digital | Profile | |
| Larry McGrath | Sr Relations | Profile | |
| Heidi Capozzi | Executive Officer | Profile | |
| David Falkowski | Executive Officer | Profile | |
| Gustavo Giraldo | Head Benefits | Profile | |
| Daniel Finke | Executive Vice President and Presidentident - Health Care Benefits Segment | Profile | |
| Alan Lotvin | Executive Vice President and Presidentident - CVS Caremark | Profile | |
| Neela Montgomery | Executive Vice President and President - CVS Pharmacy/Retail | Profile | |
| Alan MD | Ex Services | Profile | |
| Sheryl Burke | Chief Responsibility | Profile |
About CVS Health Management Performance
The success or failure of an entity such as CVS Health Corp often depends on how effective the management is. CVS Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CVS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CVS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.06 | 0.10 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.03 | 0.06 | |
| Return On Equity | 0.11 | 0.12 |
Please note, the imprecision that can be found in CVS Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CVS Health Corp. Check CVS Health's Beneish M Score to see the likelihood of CVS Health's management manipulating its earnings.
CVS Health Workforce Analysis
Traditionally, organizations such as CVS Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CVS Health within its industry.CVS Health Manpower Efficiency
Return on CVS Health Manpower
| Revenue Per Employee | 1.6M | |
| Revenue Per Executive | 7.8B | |
| Net Income Per Employee | 38.1K | |
| Net Income Per Executive | 181.4M |
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.